Biosimilars

COVID-19

Cataract Surgery

Cataract

Cataract Therapeutics

NeuroOp Guru

Clinical Diagnosis

Cornea

Dry Eye Awareness

Dry Eye

Gene Therapy

Geographic Atrophy

IOL Advances

Imaging

Glaucoma Awareness

Glaucoma Insights

Therapeutic Glaucoma

Interventional Glaucoma

Ocular Allergy

Ocular Surface Disease

Optic Relief

Optometry

Pediatrics

Pharmacy

Indispensable

Practice Management

Presbyopia

Ptosis

Refractive Surgery

Refractive

Retina

Surgery

Technology

Therapeutics

Understanding Antibiotic Resistance

Workplace

News

All News

Contributors

Money Matters

Media

All Videos

Expert Interviews

Medical World News

Podcasts

Case Based Roundtable Series

Case of the Quarter

EyeView

Grand Rounds

Insights

Rapid Readout

Viewpoints

What’s Your WhEYE?

Conferences

Conference Coverage

Conference Listing

Events

Publications

Digital Edition

Europe Ophthalmology Times

Modern Retina

Supplements and Featured Publications

Partners

Subscribe

Resources

Job Board

Articles

Urcosimod (formerly known as OK-101) has been shown to be stable for over 2 and a half years in single-use ampoules used for administration of the drug to patients. 

OKYO Pharma releases positive long-term stability data for urcosimod in neuropathic corneal pain

The decision to discontinue the trials comes shortly after the announcement that COAST missed its primary endpoint. 

Opthea discontinues COAST and ShORe trials in wet AMD

Study: No significant long-term benefits found in cocoa extract for AMD

Videos

In celebration of Ophthalmology Times 50th anniversary, we asked leading experts in the field what they see as the biggest innovation in ophthalmology in the last 5 decades.

Part 2: Biggest innovations in ophthalmology in 50 years

Ophthalmology Times - ophthalmology news, articles, and events in a timely and accurate manner for members of the ophthalmic community.

About

Advertise

Privacy

Editorial Info

Editorial Board

Terms and Conditions

Contact Us

Do Not Sell My Personal Information

Ophthalmology Times - Ophthalmology news, articles, and events

Facebook

Instagram

LinkedIn

Spotlight

Clinical

Glaucoma

View

Adapting New Users to Small Incision Lenticule Extraction (SMILE)

A Case of Refractive Correction with SMILE 

Dr. Stephen Dell, MD, offers insights into Small Incision Lenticule Extraction (SMILE), highlighting its suitability for patients with myopia and astigmatism, and discussing the latest advancements in laser technology that enhance the surgical experience and precision of the procedure.

Steven Dell, MD, provides an overview of the SMILE procedure, and shared what motivated him to adopt SMILE procedure in his practice 

Getting Started with Small Incision Lenticule Extraction (SMILE) 

Steven Dell, MD,  shares insights from his first SMILE procedure case, detailing key surgical steps and the patient's postoperative experience. 

I'm sorry, but it seems there is no article provided for me to summarize and extract key takeaways from. Could you please provide the text of the article

A Case of Refractive Correction with SMILE

EP: 1.Getting Started with Small Incision Lenticule Extraction (SMILE)

EP: 2.A Case of Refractive Correction with SMILE